# | Title | Journal | Year | Citations |
---|
1 | Caring for severe acute respiratory syndrome (SARS) patients in acute care institutions in the greater Toronto area | Canada Communicable Disease Report | 2008 | 200 |
2 | The process to establish and implement national goals and recommendations for vaccine preventable diseases in Canada under the National Immunization Strategy | Canada Communicable Disease Report | 2007 | 158 |
3 | Increased risk of tick-borne diseases with climate and environmental changes | Canada Communicable Disease Report | 2019 | 151 |
4 | Latent tuberculosis infection: An overview | Canada Communicable Disease Report | 2017 | 120 |
5 | Estimated prevalence of Hepatitis C Virus infection in Canada, 2011 | Canada Communicable Disease Report | 2014 | 117 |
6 | An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital | Canada Communicable Disease Report | 1999 | 93 |
7 | Environmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance information | Canada Communicable Disease Report | 2014 | 87 |
8 | Motivational interviewing: A powerful tool to address vaccine hesitancy | Canada Communicable Disease Report | 2020 | 81 |
9 | Big Data and the Global Public Health Intelligence Network (GPHIN) | Canada Communicable Disease Report | 2015 | 78 |
10 | HIV in Canada—Surveillance Report, 2017 | Canada Communicable Disease Report | 2018 | 75 |
11 | HIV in Canada—Surveillance Report, 2018 | Canada Communicable Disease Report | 2019 | 75 |
12 | Statement on Bacille Calmette Guérin (BCG) vaccine | Canada Communicable Disease Report | 2004 | 75 |
13 | Waterborne outbreak of gastroenteritis associated with a contaminated municipal water supply, Walkerton, Ontario, May-June 2000 | Canada Communicable Disease Report | 2000 | 74 |
14 | Infectious and congenital syphilis in Canada, 2010–2015 | Canada Communicable Disease Report | 2018 | 73 |
15 | Surveillance for Lyme disease in Canada: 2009–2015 | Canada Communicable Disease Report | 2017 | 72 |
16 | HIV in Canada—Surveillance Report, 2016 | Canada Communicable Disease Report | 2017 | 71 |
17 | Statement on motion sickness | Canada Communicable Disease Report | 2003 | 69 |
18 | CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines | Canada Communicable Disease Report | 2016 | 65 |
19 | Challenges and opportunities for public health made possible by advances in natural language processing | Canada Communicable Disease Report | 2020 | 64 |
20 | Emerging mosquito-borne bunyaviruses in Canada | Canada Communicable Disease Report | 2015 | 63 |
21 | Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS) | Canada Communicable Disease Report | 2009 | 63 |
22 | Surveillance for Lyme disease in Canada, 2009 to 2012 | Canada Communicable Disease Report | 2015 | 61 |
23 | An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on smallpox vaccination | Canada Communicable Disease Report | 2002 | 60 |
24 | Statement on new oral cholera and travellers' diarrhea vaccination | Canada Communicable Disease Report | 2005 | 58 |
25 | Optimizing communication material to address vaccine hesitancy | Canada Communicable Disease Report | 2020 | 54 |
26 | Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches | Canada Communicable Disease Report | 2016 | 53 |
27 | Reaping the benefits of Open Data in public health | Canada Communicable Disease Report | 2019 | 53 |
28 | Tuberculosis in Canada, 2016 | Canada Communicable Disease Report | 2018 | 51 |
29 | Statement on International Adoption | Canada Communicable Disease Report | 2010 | 51 |
30 | First reported case of multidrug-resistant Candida auris in Canada | Canada Communicable Disease Report | 2017 | 50 |
31 | An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers | Canada Communicable Disease Report | 1999 | 49 |
32 | Tuberculosis in Canada: 2017 | Canada Communicable Disease Report | 2019 | 47 |
33 | Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005 | Canada Communicable Disease Report | 2005 | 47 |
34 | Barriers to and facilitators of hepatitis C virus screening and testing: A scoping review | Canada Communicable Disease Report | 2018 | 43 |
35 | Increased risk of endemic mosquito-borne diseases in Canada due to climate change | Canada Communicable Disease Report | 2019 | 43 |
36 | Climate change and infectious diseases: What can we expect? | Canada Communicable Disease Report | 2019 | 42 |
37 | Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS) | Canada Communicable Disease Report | 2006 | 42 |
38 | Burden of acute gastrointestinal illness in Canada, 1999-2007: interim summary of NSAGI activities | Canada Communicable Disease Report | 2008 | 40 |
39 | Modelling scenarios of the epidemic of COVID-19 in Canada | Canada Communicable Disease Report | 2020 | 39 |
40 | Statement on immunization for Lyme disease (ACS-3). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) | Canada Communicable Disease Report | 2000 | 39 |
41 | Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS) | Canada Communicable Disease Report | 2008 | 39 |
42 | HIV in Canada—surveillance report, 2019 | Canada Communicable Disease Report | 2021 | 38 |
43 | Pertussis Surveillance in Canada: Trends to 2012 | Canada Communicable Disease Report | 2014 | 38 |
44 | Waterborne cryptosporidiosis outbreak, North Battleford, Saskatchewan, Spring 2001 | Canada Communicable Disease Report | 2001 | 38 |
45 | Gonorrhea in Canada, 2010–2015 | Canada Communicable Disease Report | 2018 | 37 |
46 | Estimates of HIV prevalence and incidence in Canada, 2005 | Canada Communicable Disease Report | 2006 | 37 |
47 | An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary Statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination | Canada Communicable Disease Report | 2001 | 36 |
48 | Assessment of a screening test to identify Lyme disease risk | Canada Communicable Disease Report | 2014 | 35 |
49 | Lyme disease: clinical diagnosis and treatment | Canada Communicable Disease Report | 2014 | 35 |
50 | The continued rise of Lyme disease in Ontario, Canada: 2017 | Canada Communicable Disease Report | 2018 | 35 |